feed,title,long_url,short_url
BioRxiv,Safety and biodistribution of NanoligomersTM targeting SARS-CoV-2 genome for treatment of COVID-19,https://biorxiv.org/cgi/content/short/2022.07.19.500688v1?rss=1,https://bit.ly/3PqTOi1
